66 results
Page 3 of 4
F-3/A
9j61lmhab56b87bsxc9g
16 Oct 15
Shelf registration (foreign) (amended)
12:00am
20-F/A
e018r6vt4tpb20 w6w
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.17
ld4ipe736h94 i5sj
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-1.1
704opx y9
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
6-K
EX-99.1
pa5a2szo
3 Mar 14
Current report (foreign)
12:00am
424B3
q2pt07y2evyyhlz65
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
7xqjn8z
30 Apr 13
Current report (foreign)
12:00am
424B3
mn14hr
15 Oct 12
Prospectus supplement
12:00am
F-1
bi5d4of
2 Oct 12
Registration statement (foreign)
12:00am
424B3
rcjz9u6ibd572n4b44
28 Mar 12
Prospectus supplement
12:00am
20-F
y6nnulg50a58
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-1
leavlkow8yhln5i 3i
6 Sep 11
Orally-Available Molecule for the Treatment of
12:00am
20FR12B/A
rtaihncqiv3 lnnm9l
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
ihz8spbm2wkgb5
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
1dzsw
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am